MarginsXMarginsX
Home › Markets › Health Care › RIGL

Rigel Pharmaceuticals Inc. (RIGL)

RIGL trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$43.73
-1.64% on the day
Market cap
$823.4M
Small cap
Revenue · 2025
$294.3M
+64.1% on 2024
Net income · 2025
$367.0M
124.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1034842/000103484226000015/0001034842-26-000015-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerRIGL on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2000
SEC CIK0001034842
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$294.3M
Net income$367.0M
Operating income$125.5M
Net margin124.7%
Operating margin42.6%
Revenue growth+64.1%
Cash$40.6M
Total assets$513.6M
P/E (computed)2.2×
P/S (computed)2.8×

Warning signs

Cash runway
Cash-flow positive
$46.6M cash at September 30, 2026
Share count, 1 year
+3.7%
2025-10-30 to 2026-11-02 · +8.0% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
-$306K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$46.6M cash; operating cash flow $22.5M a quarter.Report 2026-09-30
Shares outstanding18,829,972 (2026-11-02); 18,151,344 a year earlier; 174,369,503 three years earlier. 3y figure adjusted for splits (1-for-10 overall).Cover page 2026-11-02
Reverse splits, 3 years1; latest 1-for-10 on 2024-06-27Source 2024-06-27
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, San Francisco, California, United StatesPCAOB Form AP 2026-03-18
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $306K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$80.9M$13.2M$34.6M$46.6M$14.5M$288.2M10-Q 2026-11-05
Q2 2026
2026-06-30
$78.7M$17.3M$30.7M$60.8M$78.5M$276.8M10-Q 2026-08-04
Q1 2026
2026-03-31
$58.8M$8.7M$2.7M$24.4M$45.0M$299.8M10-Q 2026-05-05
Q4 2025
2025-12-31
$69.8M$268.1M$22.0M$40.6M$52.5M$294.3M10-K 2026-03-03
Q3 2025
2025-09-30
$69.5M$27.9M$24.0M$48.5M$60.0M$282.1M10-Q 2026-11-05
Q2 2025
2025-06-30
$101.7M$59.6M$30.5M$53.4M$60.0M$267.9M10-Q 2026-08-04
Q1 2025
2025-03-31
$53.3M$11.4M-$893K$45.7M$60.0M$203.1M10-Q 2026-05-05
Q4 2024
2024-12-31
$57.6M$14.3M$14.5M$56.7M$60.0M$179.3M10-K 2026-03-03

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-32024-08-02
Latest annual report10-K2026-03-03
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-05
Latest proxyDEFA14A2026-04-03

Source: SEC EDGAR submissions feed, 1,003 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+12.1%
1 month-5.7%
3 months+9.0%
Year to date+3.8%
1 year+11.5%
From 52-week high-13.6%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
SNDXSyndax Pharmaceuticals Inc.$9.13-3.39%$821.6M
LTGOLatigo Biotherapeutics Inc.$12.60-3.89%$835.4M
IRWDIronwood Pharmaceuticals Inc.$4.85+0.41%$802.9M
CTYCity Therapeutics Inc.$16.98-6.19%$854.6M
COLLCollegium Pharmaceutical Inc.$25.43+0.43%$790.2M
IVAInventiva S.A. American Depository Shares$3.32-9.78%$784.5M
ORICOric Pharmaceuticals Inc.$7.52-4.33%$779.5M
LXRXLexicon Pharmaceuticals Inc.$1.75-2.23%$779.2M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier